Low-Dose Olanzapine Effectively Reduces chemotherapy induced vomiting in Cancer Patients
A recent study discovered that a lower dose of Olanzapine (OLZ) is just as effective as the standard dose for chemotherapy-induced nausea and vomiting (CINV), while it also significantly reduced daytime somnolence in cancer patients, The outcomes were presented in San Antonio Breast Cancer Symposium 2023. CINV poses a significant burden on cancer patients undergoing […]